← Back to Search

Treatment for Colorectal Cancer

N/A
Recruiting
Research Sponsored by Innovis LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 months
Awards & highlights

Summary

The primary objective of this study is to obtain de-identified stool specimens from participants with colonoscopic biopsy-based histopathologic diagnosis of colorectal cancer (CRC) and/or a ≥1 cm colorectal polyp/adenoma/mass found during pre-enrollment colonoscopy that is of sufficient size to require surgical excision or complex colonoscopic polypectomy. The samples will be used for the purpose of research and development of a new molecular diagnostic test for the detection of neoplasms of the aerodigestive tract.

Eligible Conditions
  • Colorectal Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Detection of colon cancer or precancer

Find a Location

Who is running the clinical trial?

Exact Sciences CorporationIndustry Sponsor
33 Previous Clinical Trials
259,500 Total Patients Enrolled
Innovis LLCLead Sponsor
4 Previous Clinical Trials
944 Total Patients Enrolled
Gregg S BrittStudy DirectorInnovis LLC
1 Previous Clinical Trials
40 Total Patients Enrolled
~19 spots leftby Sep 2025